PAVmed Statistics
Total Valuation
PAVmed has a market cap or net worth of $17.06 million. The enterprise value is $46.15 million.
| Market Cap | 17.06M |
| Enterprise Value | 46.15M |
Important Dates
The next estimated earnings date is Tuesday, May 14, 2024, after market close.
| Earnings Date | May 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PAVmed has 9.17 million shares outstanding. The number of shares has increased by 21.78% in one year.
| Shares Outstanding | 9.17M |
| Shares Change (YoY) | +21.78% |
| Shares Change (QoQ) | +7.51% |
| Owned by Insiders (%) | 7.23% |
| Owned by Institutions (%) | 12.40% |
| Float | 8.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.96 |
| Forward PS | 2.82 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.45
| Current Ratio | 0.45 |
| Quick Ratio | 0.36 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -107.96 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -136.60% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $22,916 |
| Profits Per Employee | -$619,346 |
| Employee Count | 107 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 33.01 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.41% in the last 52 weeks. The beta is 0.83, so PAVmed's price volatility has been lower than the market average.
| Beta (1Y) | 0.83 |
| 52-Week Price Change | -76.41% |
| 50-Day Moving Average | 2.18 |
| 200-Day Moving Average | 3.73 |
| Relative Strength Index (RSI) | 41.57 |
| Average Volume (30 Days) | 63,975 |
Short Selling Information
The latest short interest is 387,674, so 4.23% of the outstanding shares have been sold short.
| Short Interest | 387,674 |
| Short Previous Month | 368,666 |
| Short % of Shares Out | 4.23% |
| Short % of Float | 4.80% |
| Short Ratio (days to cover) | 4.55 |
Income Statement
In the last 12 months, PAVmed had revenue of $2.45 million and -$66.27 million in losses. Loss per share was -$9.16.
| Revenue | 2.45M |
| Gross Profit | -3.97M |
| Operating Income | -68.80M |
| Pretax Income | -64.18M |
| Net Income | -66.27M |
| EBITDA | -60.35M |
| EBIT | -63.59M |
| Loss Per Share | -$9.16 |
Balance Sheet
The company has $19.64 million in cash and $48.73 million in debt, giving a net cash position of -$29.09 million or -$3.17 per share.
| Cash & Cash Equivalents | 19.64M |
| Total Debt | 48.73M |
| Net Cash | -29.09M |
| Net Cash Per Share | -$3.17 |
| Equity / Book Value | -53.83M |
| Book Value Per Share | -5.87 |
| Working Capital | -29.68M |
Cash Flow
In the last 12 months, operating cash flow was -$52.04 million and capital expenditures $758,000, giving a free cash flow of -$51.28 million.
| Operating Cash Flow | -52.04M |
| Capital Expenditures | 758,000 |
| Free Cash Flow | -51.28M |
| FCF Per Share | -$7.09 |
Margins
Gross margin is -161.83%, with operating and profit margins of -2,805.67% and -2,702.69%.
| Gross Margin | -161.83% |
| Operating Margin | -2,805.67% |
| Pretax Margin | -2,617.25% |
| Profit Margin | -2,702.69% |
| EBITDA Margin | -2,461.09% |
| EBIT Margin | -2,593.23% |
| FCF Margin | -2,091.27% |
Dividends & Yields
PAVmed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.78% |
| Shareholder Yield | -21.78% |
| Earnings Yield | -388.44% |
| FCF Yield | -300.57% |
Analyst Forecast
The average price target for PAVmed is $8.61, which is 362.90% higher than the current price. The consensus rating is "Hold".
| Price Target | $8.61 |
| Price Target Difference | 362.90% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 150.81% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 7, 2023. It was a reverse split with a ratio of 1:15.
| Last Split Date | Dec 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
PAVmed has an Altman Z-Score of -19.6 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.6 |
| Piotroski F-Score | 3 |